Brief: Marker Therapeutics Says On April 27 Peter Hoang, Co's President & CEO, Resigned From His Operating Role, Effective May 1
May 1 (Reuters) - Marker Therapeutics Inc MRKR.O :
* MARKER THERAPEUTICS - ON APRIL 27 PETER HOANG, CO'S
PRESIDENT &
CEO, RESIGNED FROM HIS OPERATING ROLE, EFFECTIVE MAY 1
* MARKER THERAPEUTICS - HOANG ALSO RESIGNED AS A MEMBER OF
BOARD
OF DIRECTORS EFFECTIVE IMMEDIATELY
* MARKER THERAPEUTICS - BOARD APPOINTED JUAN VERA AS
PRESIDENT AND
CEO
Source: [ID: https://bit.ly/41R9RMt]
Further company coverage: MRKR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marker Therapeutics
See all newsBrief: Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant To Advance MT-601 In Pancreatic Cancer
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
Brief: Marker Therapeutics FY Basic EPS USD -0.79